Testing effectiveness (Phase 2)UnknownNCT03576287What this trial is testingApremilast as Anti-pruritic Treatment in Patients With Prurigo NodularisWho this might be right forPrurigo Nodularis Tanja Todberg, MD 15
Large-scale testing (Phase 3)Looking for participantsNCT06516952What this trial is testingEvaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)Who this might be right forPrurigo Nodularis Incyte Corporation 330
Early research (Phase 1)Study completedNCT05405985What this trial is testingStudy to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber SyringeWho this might be right forHealthy Volunteers Galderma R&D 192
Testing effectiveness (Phase 2)Study completedNCT00507832What this trial is testingEvaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic DiseaseWho this might be right forPrurigo Nodularis University Hospital Muenster 30
Large-scale testing (Phase 3)Study completedNCT05052983What this trial is testingEvaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo NodularisWho this might be right forPrurigo Nodularis Galderma R&D 34
Large-scale testing (Phase 3)Study completedNCT04202679What this trial is testingStudy of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)Who this might be right forNeurodermatitis Sanofi 160
Early research (Phase 1)Study completedNCT04944862What this trial is testingCDX-0159 in Patients With Prurigo NodularisWho this might be right forPrurigo Nodularis Celldex Therapeutics 24
Not applicableLooking for participantsNCT05928169What this trial is testingDeterminants of Chronic Inflammatory Skin Disease TrajectoriesWho this might be right forAtopic DermatitisPsoriasisLichen Planus+5 more University Hospital Schleswig-Holstein 1,000
Not applicableLooking for participantsNCT05316805What this trial is testingChina Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment ProjectWho this might be right forAtopic Dermatitis EczemaPrurigo Nodularis Peking University First Hospital 100,000
Not applicableUnknownNCT04681300What this trial is testingTranscriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencingWho this might be right forPrurigo NodularisAtopic Dermatitis Assistance Publique - Hôpitaux de Paris 20
Large-scale testing (Phase 3)Study completedNCT03497975What this trial is testingPRISM Study-Pruritus Relief Through Itch Scratch ModulationWho this might be right forPrurigo Nodularis Trevi Therapeutics 353
Large-scale testing (Phase 3)Looking for participantsNCT06779136What this trial is testingPhase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo NodularisWho this might be right forPrurigo Nodularis Shanghai Mabgeek Biotech.Co.Ltd 160
Testing effectiveness (Phase 2)Study completedNCT05061693What this trial is testingEvaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo NodularisWho this might be right forPrurigo Nodularis Incyte Corporation 146
Not applicableLooking for participantsNCT07276425What this trial is testingEarly and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo NodularisWho this might be right forPrurigo Nodularis (PN) UMC Utrecht 40
Large-scale testing (Phase 3)Study completedNCT04183335What this trial is testingStudy of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)Who this might be right forNeurodermatitis Sanofi 151
Large-scale testing (Phase 3)Active Not RecruitingNCT06516965What this trial is testingEvaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)Who this might be right forPrurigo Nodularis Incyte Corporation 346
Early research (Phase 1)Looking for participantsNCT06342713What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological DiseasesWho this might be right forHealthy ParticipantsHealthy SubjectsHealthy Volunteers+4 more BeiGene 211
Not applicableUnknownNCT06201715What this trial is testingEfficacy and Safety of Tofacitinib in Patients With Prurigo NodularisWho this might be right forPrurigo NodularisItch Second Affiliated Hospital, School of Medicine, Zhejiang University 24
Early research (Phase 1)Study completedNCT06213831What this trial is testingEvaluate the Safety and Tolerability of Maximal Use Ruxolitinib CreamWho this might be right forPrurigo Nodularis Incyte Corporation 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT06366750What this trial is testingBarzolvolimab in Patients With Prurigo NodularisWho this might be right forPrurigo Nodularis Celldex Therapeutics 140